权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Epigenetic regulation of bile acids in health and disease

胆汁酸在健康和疾病中的表观遗传调控

基本信息

批准号：
9903114
负责人：
Alexander Louis Ticho
金额：
$ 5.05万
依托单位：
UNIVERSITY OF ILLINOIS AT CHICAGO
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-05-22 至 2021-05-07
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9903114
关键词：
ASBT protein Adult Affect Animal Model Animals Bile Acid Biosynthesis Pathway Bile Acids Biological Assay CYP7A1 gene Carrier Proteins Colitis Colon DNA DNA Methylation DNA Modification Process Data Development Diarrhea Diet Disease Distal Early Intervention Early identification Electrolytes Enterocytes Enzymes Epigenetic Process Epithelial Epithelium Exposure to FGF19 gene Feedback Fetal Development Fluids and Secretions Functional disorder Gene Expression Genes Genetic Transcription Half-Life Health Hepatic Homeostasis Hypermethylation In Vitro Inflammation Inflammatory Inflammatory Bowel Diseases Intestines Lead Link Lipids Liver Luciferases Measures Mediating Messenger RNA Methods Methylation Modeling Mus Pathogenesis Pathway interactions Patients Phosphoric Monoester Hydrolases Phosphotransferases Physiological Predisposing Factor Predisposition Production Protein Kinase C Protein Tyrosine Phosphatase Regulation Risk Risk Factors Rodent Signal Pathway Symptoms Testing Time Transgenic Mice Weaning absorption base cytokine dextran sulfate sodium induced colitis disorder risk drug discovery epigenetic regulation high risk ileum in vivo in vivo Model in vivo imaging system inflammatory disease of the intestine innovation luciferin luminal membrane luminescence mRNA Expression mouse model new therapeutic target non-invasive monitor novel offspring overexpression promoter temporal measurement time use tool uptake

项目摘要

PROJECT SUMMARY Despite major advancements in our understanding of the pathophysiology of inflammatory bowel disease, relatively little is known with respect to epigenetic factors that predispose to development of IBD. Epigenetic changes, including DNA methylation, have been implicated as risk factors for these debilitating diseases. Elevated intestinal luminal bile acids are known to exacerbate IBD symptoms, but it is not known whether changes in DNA methylation alter bile acid regulation and, thus, contribute to the severe intestinal inflammation. Luminal bile acids can become elevated either as a result of increased hepatic bile acid synthesis or decreased intestinal bile acid reabsorption. Fibroblast growth factor 19 (FGF19; FGF15 in rodents), which is induced in the ileum by reabsorbed bile acids, circulates to the liver to inhibit bile acid synthesis. Our preliminary data showed that in a dietary model of DNA hypermethylation, ileal FGF15 mRNA is repressed and the hepatic bile acid synthesis gene CYP7A1 is induced. We demonstrated that CpG methylation of the FGF15 gene is increased in this model, suggesting that methylation represses FGF15 expression. To establish the novel link between epigenetic changes and bile acid regulation, our proposed studies will test the hypothesis that DNA hypermethylation leads to dysregulation of bile acid synthesis and absorption, contributing to increased susceptibility to intestinal inflammation. The studies proposed in Specific Aim 1 will investigate the mechanisms by which DNA methylation decreases FGF15/19 expression and causes bile acid dysregulation using sophisticated in vitro and in vivo models. We will also explore the proposed link between elevated luminal bile acids and susceptibility to inflammation using established models of intestinal inflammation and transgenic mice with intestine-specific FGF15 overexpression. It is also known that intestinal bile acid absorption via the apical sodium-dependent bile acid transporter (ASBT) is rapidly modulated via phosphatases and kinases, the expression of which can be altered by DNA methylation. Thus, studies in Specific Aim 2 will investigate the effects of DNA methylation on bile acid absorption using a novel luminescence-based method for measuring bile acid uptake in live animals. Our preliminary data indicate that this method is suitable for measuring ASBT function in vitro. Our proposed studies will establish an innovative method for noninvasive, real-time measurement of bile acid absorption in animals. We will use this method to assess bile acid absorption in animal models of DNA hypermethylation. The methods established in Specific Aim 2 will provide a novel investigative tool for measuring bile acid transport in vitro and in vivo. Overall, the successful completion of the proposed studies will illuminate the mechanisms underlying how epigenetic factors such as DNA methylation contribute to bile acid dysregulation and predisposition to intestinal inflammation. This will identify novel therapeutic targets for IBD and may allow for early identification and intervention for patients with a predisposition for IBD.

项目总结